S-ketamine is one of 107 small molecule programs targeting Cognitive impairment. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
72 competitors in Cognitive Impairment
Marinol
Brintellix
Intropin
Avandia
Epidiolex
Coumadin
Pradaxa
Prozac
Precedex
Adrenaline
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details